Mediastinum

Cardiovascular Ultrasound Market to Reach $4.2 Billion by 2032, exhibiting a CAGR of 5.8% from 2023 to 2032: Allied Market Research

Retrieved on: 
Wednesday, December 6, 2023

PORTLAND, Ore., Dec. 6, 2023 /PRNewswire/ -- Allied Market Research published a report, titled, "Cardiovascular Ultrasound Market by Type (Transthoracic Echocardiogram, Transesophageal Echocardiogram, Stress Echocardiogram, and Others), Technology (2D, 3D & 4D, and Others), Display Type (Color and Black & White), and End User (Hospital, Cardiac Centers, and Others): Global Opportunity Analysis and Industry Forecast, 2023-2032". According to the report, the global cardiovascular ultrasound market was valued for $2.4 Billion in 2022, and is projected to reach $4.2 Billion by 2032, registering a CAGR of 5.8% from 2023 to 2032.

Key Points: 
  • The 2D segment to maintain its leadership status throughout the forecast period.
  • However, the cardiac centers segment is projected to manifest a significant CAGR of 6.4% from 2023 to 2032.
  • Based on region, North America held the highest market share in terms of revenue in 2022, accounting for more than two-fifths of the global cardiovascular ultrasound market revenue.
  • This is attributed to high presence of cardiovascular ultrasound drug manufacturers in North America and rising prevalence of chronic disease such as cancer and chronic pain.

Cardiovascular Ultrasound Market to Reach $4.2 Billion by 2032, exhibiting a CAGR of 5.8% from 2023 to 2032: Allied Market Research

Retrieved on: 
Wednesday, December 6, 2023

PORTLAND, Ore., Dec. 6, 2023 /PRNewswire/ -- Allied Market Research published a report, titled, "Cardiovascular Ultrasound Market by Type (Transthoracic Echocardiogram, Transesophageal Echocardiogram, Stress Echocardiogram, and Others), Technology (2D, 3D & 4D, and Others), Display Type (Color and Black & White), and End User (Hospital, Cardiac Centers, and Others): Global Opportunity Analysis and Industry Forecast, 2023-2032". According to the report, the global cardiovascular ultrasound market was valued for $2.4 Billion in 2022, and is projected to reach $4.2 Billion by 2032, registering a CAGR of 5.8% from 2023 to 2032.

Key Points: 
  • The 2D segment to maintain its leadership status throughout the forecast period.
  • However, the cardiac centers segment is projected to manifest a significant CAGR of 6.4% from 2023 to 2032.
  • Based on region, North America held the highest market share in terms of revenue in 2022, accounting for more than two-fifths of the global cardiovascular ultrasound market revenue.
  • This is attributed to high presence of cardiovascular ultrasound drug manufacturers in North America and rising prevalence of chronic disease such as cancer and chronic pain.

The Inner Circle Acknowledges, Dr. Diana Kolman as a Pinnacle Platinum Healthcare Professional for her work as an Interventional Pulmonologist

Retrieved on: 
Thursday, July 6, 2023

MOUNT LAUREL, N.J., July 6, 2023 /PRNewswire/ -- Prominently featured in The Inner Circle, Dr. Diana Kolman is acknowledged as a Pinnacle Platinum Healthcare Professional for her work as an Interventional Pulmonologist.

Key Points: 
  • MOUNT LAUREL, N.J., July 6, 2023 /PRNewswire/ -- Prominently featured in The Inner Circle, Dr. Diana Kolman is acknowledged as a Pinnacle Platinum Healthcare Professional for her work as an Interventional Pulmonologist.
  • Dr. Kolman began her pursuit of higher education at Rutgers University where she received a BS in Biology and Physics.
  • She is known for being clear and honest with her patients regarding their diagnoses and works to give them several options for treatment.
  • According to Dr. Kolman, the physicians at Capital Health – Pulmonology Specialists diagnose and treat conditions that affect the lungs and respiratory system.

Min Kim, M.D. Has Been Reviewed & Approved By TX Top Docs

Retrieved on: 
Thursday, June 9, 2022

SCOTCH PLAINS, N.J., June 9, 2022  /PRNewswire-PRWeb/ -- TX Top Doc, Dr. Min Kim is committed to providing the best thoracic surgical care. Dr. Kim is a board certified thoracic surgeon who practices in the Houston area. He specializes in the surgical treatment of diseases involving the chest. This includes the treatment of the airway, lungs, pleura, diaphragm, esophagus, chest wall and mediastinum.

Key Points: 
  • has been reviewed and approved by TX Top Docs for 2022.
  • SCOTCH PLAINS, N.J., June 9, 2022 /PRNewswire-PRWeb/ -- TX Top Doc, Dr. Min Kim is committed to providing the best thoracic surgical care.
  • TX Top Docs only reviews and approves providers based on merit after they have been extensively vetted.
  • TX Top Docs is a division of USA Top Docs which allows patients to meet providers online before making their appointment.

Olympus Supports CMS Coverage Decision for Lung Cancer Screening

Retrieved on: 
Tuesday, May 24, 2022

CENTER VALLEY, Pa., May 24, 2022 /PRNewswire/ -- Olympus, a global leader in designing and delivering innovative medical technology solutions, announced its support for the Centers for Medicare & Medicaid Services (CMS) decision to expand lung cancer screening eligibility for those covered by Medicare.

Key Points: 
  • CENTER VALLEY, Pa., May 24, 2022 /PRNewswire/ -- Olympus, a global leader in designing and delivering innovative medical technology solutions, announced its support for the Centers for Medicare & Medicaid Services (CMS) decision to expand lung cancer screening eligibility for those covered by Medicare.
  • Earlier screening and detection may save the lives of those diagnosed with non-small cell lung cancer," said Paul Skodny, Executive Director of Global Health Economics and Market Access at Olympus Corporation of the Americas.
  • "Still, there is much work to be done to align CMS coverage through Medicare and Medicaid with lung cancer screening guidance so that the barriers to screening are eliminated."
  • Methods for staging non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.

FUJIFILM Sonosite announces the availability of Sonosite LX, the industry leader’s latest premium point-of-care ultrasound system, in Canada

Retrieved on: 
Monday, April 18, 2022

Sonosite LX has a large, adaptable 21.3 clinical display that extends, rotates and tilts to accommodate the varied clinical environments at the bedside.

Key Points: 
  • Sonosite LX has a large, adaptable 21.3 clinical display that extends, rotates and tilts to accommodate the varied clinical environments at the bedside.
  • The Sonosite LX is compatible with the redesigned family of transducers launched with Sonosite PX that have dedicated exam types for study-specific imaging and workflow optimization.
  • As with all Sonosite point of care ultrasound systems, Sonosite LX is built to legendary durability, reliability, and ease of use standards.
  • FUJIFILM Sonosite, Inc. is the innovator and world leader in bedside and point-of-care ultrasound, and an industry leader in ultra-high frequency micro-ultrasound technology.

FUJIFILM Sonosite launches Sonosite LX, the industry leader’s latest premium point-of-care ultrasound system

Retrieved on: 
Tuesday, February 15, 2022

Sonosite LX was inspired by and designed with clinician partners, focusing on the evolving ways ultrasound can support the quadruple aim at the point of care, wherever that may be, said Rich Fabian, president and COO, FUJIFILM Sonosite.

Key Points: 
  • Sonosite LX was inspired by and designed with clinician partners, focusing on the evolving ways ultrasound can support the quadruple aim at the point of care, wherever that may be, said Rich Fabian, president and COO, FUJIFILM Sonosite.
  • Sonosite LX has a large, adaptable 21.3 clinical display that extends, rotates and tilts to accommodate the varied clinical environments at the bedside.
  • As with all Sonosite point of care ultrasound systems, Sonosite LX is built to legendary durability, reliability, and ease of use standards.
  • FUJIFILM Sonosite, Inc. is the innovator and world leader in bedside and point-of-care ultrasound, and an industry leader in ultra-high frequency micro-ultrasound technology.